Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at CZK 438.6B, ahead of Merck & Co (CZK 324.1B) and Novartis (CZK 254.5B). Figures as of 19 Nov 2026, 05:12 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonCZK 438.6B
- Median
- CZK 12.8B
- Combined market value
- CZK 112.58T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | CZK 438.6B | CZK 14.61T | CZK 6,068.72 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | CZK 324.1B | CZK 7.56T | CZK 3,066.18 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | CZK 254.5B | CZK 6.52T | CZK 3,454.07 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | CZK 227.2B | CZK 2.71T | CZK 1,325.46 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | CZK 189.7B | CZK 4.03T | CZK 2,325.12 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | CZK 189.1B | CZK 2.52T | CZK 1,048.62 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | CZK 161.7B | CZK 27.41T | CZK 30,772.00 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | CZK 127.1B | CZK 6.17T | CZK 3,978.16 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | CZK 116.4B | CZK 11.25T | CZK 6,364.92 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | CZK 113.2B | CZK 3.03T | CZK 11,938.27 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | CZK 101.2B | CZK 1.03T | CZK 8,981.80 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | CZK 100.3B | CZK 2.17T | CZK 1,081.11 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | CZK 87.4B | CZK 3.87T | CZK 877.48 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | CZK 82.9B | CZK 1.51T | CZK 473.35 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | CZK 79.1B | CZK 1.1T | CZK 939.79 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | CZK 69.4B | CZK 2.18T | CZK 21,042.01 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | CZK 51.5B | CZK 773.7B | CZK 1,904.29 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | CZK 38.2B | CZK 699.4B | CZK 1,134.30 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | CZK 36.9B | CZK 445.3B | CZK 3,324.78 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | CZK 34.7B | CZK 547.2B | CZK 12,848.24 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | CZK 31.6B | CZK 624.5B | CZK 861.91 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | CZK 31B | CZK 353.9B | CZK 5,513.92 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | CZK 29.4B | CZK 517.4B | CZK 451.32 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | CZK 29.2B | CZK 264.8B | CZK 1,367.08 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | CZK 25.4B | CZK 3.56T | CZK 624.45 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | CZK 21.9B | CZK 112B | CZK 1,340.37 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | CZK 20.4B | CZK 128.3B | CZK 188.49 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | CZK 20.1B | CZK 70.1B | CZK 361.63 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | CZK 15.2B | CZK 394.6B | CZK 6,015.98 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | CZK 13.8B | CZK 878.7B | CZK 1,528.20 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | CZK 12.8B | CZK 163.3B | CZK 1,865.57 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | CZK 12.7B | CZK 338.2B | CZK 1,736.05 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | CZK 12.1B | CZK 297B | CZK 594.19 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | CZK 11.4B | CZK 584.9B | CZK 2,666.05 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | CZK 8.6B | CZK 175.2B | CZK 1,042.61 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | CZK 8.3B | CZK 101.5B | CZK 609.54 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | CZK 8B | CZK 189.8B | CZK 6,791.76 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | CZK 7.9B | CZK 141.2B | CZK 3,476.77 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | CZK 7.2B | CZK 156.9B | CZK 2,982.06 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | CZK 6.9B | CZK 107.7B | CZK 618.89 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | CZK 6.6B | CZK 134.4B | CZK 2,058.29 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | CZK 6.3B | CZK 169.6B | CZK 486.92 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | CZK 5.7B | CZK 88.7B | CZK 648.04 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | CZK 5B | CZK 135.6B | CZK 959.38 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | CZK 5B | CZK 186.9B | CZK 233.67 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | CZK 4.4B | CZK 205.8B | CZK 8,858.95 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | CZK 3.9B | CZK 133B | CZK 6,647.55 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CZK 3.7B | CZK 166.2B | CZK 2,115.26 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | CZK 3.6B | CZK 277.9B | CZK 333.37 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | CZK 2.9B | CZK 184.7B | CZK 2,829.84 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | CZK 2.7B | CZK 159.1B | CZK 1,142.09 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | CZK 2.7B | CZK 165.1B | CZK 1,508.61 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | CZK 2.1B | CZK 107.3B | CZK 1,118.05 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | CZK 1.9B | CZK 214.4B | CZK 2,257.91 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | CZK 1.8B | CZK 222.4B | CZK 1,471.45 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | CZK 1.6B | CZK 107.5B | CZK 306.22 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | CZK 1.4B | CZK 100.8B | CZK 920.66 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | CZK 1.2B | CZK 183.7B | CZK 2,649.14 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | CZK 1.1B | CZK 105.2B | CZK 1,868.91 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | CZK 1B | CZK 144.5B | CZK 2,130.62 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | CZK 484.4M | CZK 117.2B | CZK 2,778.66 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2542 CZK).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (CZK 438.6B), Merck & Co (CZK 324.1B) and Novartis (CZK 254.5B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 19 Nov 2026, 05:12 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of CZK 112.58T as of 19 Nov 2026, 05:12 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.